Gusto Global
John Fennebresque is a seasoned professional with extensive experience in consulting, investment banking, and entrepreneurship. As the founder of Fennebresque & Co. since 2007, John provides specialized services to a diverse range of clients across several sectors, including technology and healthcare. In addition, John is a co-founder of Gusto Global, which focuses on microbiome-based diagnostics and therapies, and serves on the management team of ACRE Investment Management, LLC, where the mission centers on valuing natural capital. John's governance roles include board memberships at the UNC Nutrition Research Institute and past positions with several organizations, such as ESSENTRA PACKAGING U.S. INC. and the North Carolina Museum of Art. John holds an MBA in Finance from Columbia Business School and has participated in executive education at Harvard Business School.
This person is not in any teams
This person is not in any offices
Gusto Global
Gusto Global is a biotechnology company that revolutionizes human health by building the discovery and development platform that applies ecological principles to restore key functionalities of a healthy microbiome. The company's platform integrates advanced computational and microbiological tools to discover and develop novel LiveBiotherapeutic Products (LBPs) with unprecedented speed and efficiency. Its ecological approach combines proprietary bioinformatics, AI, and microbiology expertise to identify differences in core microbiome functionalities between healthy and unhealthy individuals. Gusto's live biotherapeutics and companion diagnostics offer the potential for safer and more effective patient-centric care through disease prevention, early detection/diagnosis, intervention, and monitoring.Gusto Global was founded in 2015 and is headquartered in Charlotte, North Carolina.